The neuroprotective effect of nicotine in Parkinson’s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage

Clinical evidence points to neuroprotective effects of smoking in Parkinson’s disease (PD), but the molecular mechanisms remain unclear. We investigated the pharmacological pathways involved in these neuroprotective effects, which could provide novel ideas for developing targeted neuroprotective tre...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Justin Y.D. Lu, Ping Su, James E.M. Barber, Joanne E. Nash, Anh D. Le, Fang Liu, Albert H.C. Wong
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	PeerJ Inc. 2017-10-01
Saila:	PeerJ
Gaiak:	Parkinson’s disease Nicotine Smoking MPP+ 6-OHDA Mouse
Sarrera elektronikoa:	https://peerj.com/articles/3933.pdf
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!